| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/0959-437X(94)90100-7 |
| P698 | PubMed publication ID | 8193531 |
| P2093 | author name string | Evan GI | |
| Fanidi A | |||
| Harrington EA | |||
| P2860 | cites work | Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death | Q24312211 |
| Lethal effect of the anti-Fas antibody in mice | Q36696599 | ||
| P433 | issue | 1 | |
| P921 | main subject | cell death | Q2383867 |
| P304 | page(s) | 120-129 | |
| P577 | publication date | 1994-02-01 | |
| P1433 | published in | Current Opinion in Genetics & Development | Q13505684 |
| P1476 | title | Oncogenes and cell death | |
| P478 | volume | 4 |
| Q46031166 | A 'non-canonical' DNA-binding element mediates the response of the Fas-ligand promoter to c-Myc. |
| Q33908317 | A cell cycle-dependent internal ribosome entry site |
| Q63408384 | A matter of life and death |
| Q38295120 | A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins |
| Q34160264 | ALG-2: a Ca2+ -binding modulator protein involved in cell proliferation and in cell death |
| Q54998142 | Analysis of the c-myc, K-ras and p53 genes in methylcholanthrene-induced mouse sarcomas. |
| Q34558572 | Angiotensin AT2 receptor ligands: do they have potential as future treatments for neurological disease? |
| Q37286351 | Anti cancer effects of curcumin: cycle of life and death |
| Q74326180 | Anti-apoptotic signaling by a colony-stimulating factor-1 receptor/insulin receptor chimera with a juxtamembrane deletion |
| Q41140311 | Antiangiogenis restricted tumor dormancy |
| Q73979602 | Apoptosis |
| Q41194157 | Apoptosis and cancer risk assessment |
| Q41290168 | Apoptosis and gastrointestinal pharmacology. |
| Q37987451 | Apoptosis and its control in cell culture systems |
| Q55480611 | Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins. |
| Q71976278 | Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA--in vitro and in vivo studies |
| Q34395580 | Apoptosis regulators and their role in tumorigenesis |
| Q34060908 | Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids |
| Q40976644 | Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene |
| Q50528327 | Apoptotic condensations in M-phase cells. |
| Q36145387 | Apoptotic markers for primary brain tumor prognosis |
| Q35897882 | Avicins: triterpenoid saponins from Acacia victoriae (Bentham) induce apoptosis by mitochondrial perturbation |
| Q24290366 | BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma |
| Q39467304 | Biphasic c-Myc protein expression during gossypol-induced apoptosis in rat spermatocytes |
| Q41016751 | Biphasic response as a mechanism against mutant takeover in tissue homeostasis circuits. |
| Q24672398 | Calcineurin functions in Ca(2+)-activated cell death in mammalian cells |
| Q41495147 | Cancer--a matter of life and cell death |
| Q41228037 | Carcinogenesis: basic principles |
| Q41311824 | Cell cycle: on target with Myc. |
| Q33796376 | Cell proliferation and apoptosis |
| Q33735445 | Cellular responses to radiation and risk of breast cancer |
| Q37592353 | Characterization of dRFX2, a novel RFX family protein in Drosophila |
| Q33558204 | Conversion of a radioresistant phenotype to a more sensitive one by disabling erbB receptor signaling in human cancer cells |
| Q39588808 | Cyclophosphamide-induced apoptosis in A431 cells is inhibited by fucosyltransferase IV. |
| Q36673264 | DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury. |
| Q31031668 | Deciphering c-MYC-regulated genes in two distinct tissues. |
| Q73568293 | Decreased thymosin beta4 in apoptosis induced by a variety of antitumor drugs |
| Q42208169 | Differential regulation of human Eag1 channel expression by serum and epidermal growth factor in lung and breast cancer cells |
| Q34897529 | Distinct thresholds govern Myc's biological output in vivo |
| Q71802927 | Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression |
| Q54089304 | Dose-dependent reduction of apoptosis in nutrient-limited cultures of NS/0 myeloma cells transfected with the E1B-19K adenoviral gene. |
| Q34782774 | Drug development of MET inhibitors: targeting oncogene addiction and expedience |
| Q47611157 | EZH2 promotes neoplastic transformation through VAV interaction-dependent extranuclear mechanisms. |
| Q47071611 | Ectopic cyclin E expression induces premature entry into S phase and disrupts pattern formation in the Drosophila eye imaginal disc |
| Q34012593 | Ectopic expression of DREF induces DNA synthesis, apoptosis, and unusual morphogenesis in the Drosophila eye imaginal disc: possible interaction with Polycomb and trithorax group proteins |
| Q41075838 | Ectopic expression of dE2F and dDP induces cell proliferation and death in the Drosophila eye |
| Q52177924 | Effects of EGF and TGFbeta1 on c-myc gene expression and DNA synthesis in embryonic hamster palate mesenchymal cells. |
| Q73567229 | Effects of deoxyribonucleosides and cell-stimulation on frequencies of ultraviolet-B-induced micronuclei in human peripheral blood lymphocytes |
| Q44102597 | Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells |
| Q40848822 | Epidermal stem cells: markers, patterning and the control of stem cell fate |
| Q39132142 | Epstein-Barr virus in the pathogenesis of oral cancers. |
| Q57385096 | Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes |
| Q38313969 | Expression of Fas ligand in activated T cells is regulated by c-Myc |
| Q42474607 | Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. |
| Q24309392 | Expression of galectin-3 modulates T-cell growth and apoptosis |
| Q41145664 | Failure to activate interleukin 1beta-converting enzyme-like proteases and to cleave retinoblastoma protein in drug-resistant cells |
| Q73019392 | Fas-induced apoptosis in human malignant melanoma cell lines is associated with the activation of the p34(cdc2)-related PITSLRE protein kinases |
| Q35764388 | Finding cancer's weakest link |
| Q40495493 | From AIDS to parasite infection: pathogen-mediated subversion of programmed cell death as a mechanism for immune dysregulation |
| Q37657402 | Fumonisins and Alternaria alternata lycopersici toxins: sphinganine analog mycotoxins induce apoptosis in monkey kidney cells |
| Q42812461 | Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras. |
| Q40022032 | Human Bak induces cell death in Schizosaccharomyces pombe with morphological changes similar to those with apoptosis in mammalian cells |
| Q73074009 | Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis |
| Q29618396 | Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours |
| Q42801796 | Identification of a novel Krüppel-associated box domain protein, Krim-1, that interacts with c-Myc and inhibits its oncogenic activity |
| Q41137473 | Importance of and approaches to quantification of hepatocyte apoptosis |
| Q72275803 | Induction of apoptosis in oxygen-deprived cultures of hybridoma cells |
| Q33911303 | Induction of the apoptosis inhibitor ARC by Ras in human cancers |
| Q36308821 | Influence of transarterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor and basic fibroblast growth factor in rat with Walker-256 transplanted hepatoma: An experimental study |
| Q38394369 | Inhibition of neurogenic precursor proliferation by antisense alpha thyroid hormone receptor oligonucleotides |
| Q29547663 | Live or let die: the cell's response to p53 |
| Q39104248 | Loss of P53 facilitates invasion and metastasis of prostate cancer cells |
| Q40942893 | Measurement of apoptotic cells in peripheral blood. |
| Q33667315 | Mechanisms of apoptosis by c-Myc |
| Q36973284 | Mechanisms of oncogenic cooperation in cancer initiation and metastasis. |
| Q37728696 | Migfilin sensitizes cisplatin-induced apoptosis in human glioma cells in vitro |
| Q36084770 | Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway |
| Q41489300 | Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia |
| Q73534491 | Molecular genetics, natural history and the demise of childhood leukaemia |
| Q33711590 | Molecular genetics, natural history and the demise of childhood leukaemia |
| Q35150661 | Mxi1 and mxi1-0 antagonize N-myc function and independently mediate apoptosis in neuroblastoma |
| Q74628444 | Myc activation reduces fibroblast clonogenicity via an apoptotic mechanism that can be suppressed by a soluble paracrine factor |
| Q41298476 | Myc: a single gene controls both proliferation and apoptosis in mammalian cells |
| Q98281006 | NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways |
| Q41095370 | NSAID-induced apoptosis in Rous sarcoma virus-transformed chicken embryo fibroblasts is dependent on v-src and c-myc and is inhibited by bcl-2. |
| Q41372777 | New perspectives in clinical oncology from angiogenesis research |
| Q34608767 | On the origin, evolution, and nature of programmed cell death: a timeline of four billion years |
| Q36795978 | Oncogene-dependent apoptosis is mediated by caspase-9. |
| Q36547736 | Oncogene-dependent tumor suppression: using the dark side of the force for cancer therapy. |
| Q41654945 | Oncogenes in tumor metabolism, tumorigenesis, and apoptosis |
| Q24290150 | Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts |
| Q28575320 | Overexpression of the transmembrane tyrosine phosphatase LAR activates the caspase pathway and induces apoptosis |
| Q34476981 | Pathways of apoptosis and the modulation of cell death in cancer |
| Q35852309 | Pathways of apoptotic and non-apoptotic death in tumour cells |
| Q24794835 | Possible attenuation of the G2 DNA damage cell cycle checkpoint in HeLa cells by extremely low frequency (ELF) electromagnetic fields |
| Q33699455 | Programmed cell death in the terminal endbud |
| Q28189476 | Proliferation, cell cycle and apoptosis in cancer |
| Q33889305 | Protooncogenes as mediators of apoptosis |
| Q41101646 | Ras activation leads to cell proliferation or apoptotic cell death upon interleukin-2 stimulation or lymphokine deprivation, respectively |
| Q33885465 | Regulation and function of the p53-related proteins: same family, different rules |
| Q36843515 | Regulation of apoptosis by XIAP ubiquitin-ligase activity |
| Q40022933 | Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts |
| Q40850269 | SV40 T/t-antigens sensitize mammary gland epithelial cells to oxidative stress and apoptosis |
| Q40406776 | Signal transduction by Ras-like GTPases: a potential target for anticancer drugs |
| Q48769445 | Slowly triggered excitotoxicity occurs by necrosis in cortical cultures |
| Q57012511 | Spermine triggers the activation of caspase-3 in a cell-free model of apoptosis |
| Q36294755 | Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. |
| Q30469710 | Src phosphorylates the insulin-like growth factor type I receptor on the autophosphorylation sites. Requirement for transformation by src. |
| Q36397702 | Suppression of P-gp induced multiple drug resistance in a drug resistant gastric cancer cell line by overexpression of Fas |
| Q34432563 | Systematically characterizing and prioritizing chemosensitivity related gene based on Gene Ontology and protein interaction network |
| Q33927454 | The ALG-2/AIP-complex, a modulator at the interface between cell proliferation and cell death? A hypothesis |
| Q40715456 | The anti-metastatic agent imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate induces endothelial cell apoptosis by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase signaling pathway |
| Q41462680 | The c-Jun transcription factor--bipotential mediator of neuronal death, survival and regeneration |
| Q37325443 | The curious case of the tumour virus: 50 years of Burkitt's lymphoma |
| Q73026350 | The induction of apoptosis in human cervical carcinoma (HeLa) cells by gamma-linolenic acid |
| Q41506187 | The molecular regulation of apoptosis and implications for radiation oncology |
| Q53412655 | The paradox of E2F1: oncogene and tumor suppressor gene. |
| Q41523232 | The role of apoptosis in intestinal disease |
| Q24316156 | Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation |
| Q28364864 | Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation |
| Q40024169 | Transformed cells require continuous activity of RNA polymerase II to resist oncogene-induced apoptosis |
| Q77401530 | Traps to catch unwary oncogenes |
| Q24802908 | Tyrosine kinase signalling in breast cancer |
| Q77399688 | [The avian peripheral olfactory system: model for study of apoptosis and cellular regeneration] |
| Q40466009 | bcl‐2, a novel reguator of cell death |
| Q39539367 | c-Myc influences olaquindox-induced apoptosis in human hepatoma G2 cells |
| Q35194892 | c-Myc promotes differentiation of human epidermal stem cells |
| Q40443976 | c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release |
| Q40470965 | manipulation of cell death — the development of novel strategies for the treatment of gastrointestinal disease |
| Q35179351 | p38 mitogen-activated protein kinase/activator protein-1 involved in serum deprivation-induced human alkaline ceramidase 2 upregulation |
| Q73322475 | v-Jun sensitizes cells to apoptosis by a mechanism involving mitochondrial cytochrome C release |
Search more.